Spyre Therapeutics Inc
SYRE32.760USD
+0.880+2.76%
Close 12/31, 16:00（ET）Quotes delayed by 15 min
1.98BMarket Cap
LossP/E TTM
Spyre Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
-100.00%
EPS(YoY)
-4.42
91.00%
Analyst Rating
STRONG BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of -100.00%.
What is the Earnings Per Share (EPS) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -4.423, with a year-on-year change of 91.00%.
What is the net income of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its net income was -208.02M, with a year-on-year change of 38.60%.
What is the net margin of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -115.22%, with a year-on-year change of 91.60%.
What is the Return on Assets (ROA) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -43.78%, with a year-on-year change of 73.32%.
What is the operating profit of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its operating profit was -208.57M, with a year-on-year change of -77.33%.
What are the current assets of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its current assets were 608.47M, with a year-on-year change of 78.16%.
What are the total assets of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its total assets of Spyre Therapeutics Inc were 608.48M, with a year-on-year change of 77.99%.
What are the total liabilities of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its total liabilities of Spyre Therapeutics Inc were 90.68M, with a year-on-year change of 23.73%.
What is the total equity of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its total equity of Spyre Therapeutics Inc was 517.80M, with a year-on-year change of 92.80%.
What is the net operating income of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its net operating income of Spyre Therapeutics Inc was -208.02M, with a year-on-year change of 38.60%.
What is the net investment of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its net investment of Spyre Therapeutics Inc was -353.29M, with a year-on-year change of -225.93%.
What is the net financing of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2024 earnings report, its net financing of Spyre Therapeutics Inc was 410.91M, with a year-on-year change of 13.80%.
